
James C. Fang
Articles
-
Jan 22, 2025 |
klaviyo.com | James C. Fang
Nearly 98% of a brand’s website traffic is anonymous. And for marketers, it’s getting harder to identify and engage these anonymous visitors. Browsers like Safari are tightening cookie restrictions, limiting the time you can track user data to as little as 7 days. What does this mean for you? Missed opportunities. Without knowing what products people are browsing, what they’ve added to their cart or what they abandoned, you can’t engage them effectively.
-
Mar 18, 2024 |
newsbreak.com | James C. Fang
Welcome to NewsBreak, an open platform where diverse perspectives converge. Our contributor network of tens of thousands of creators appears alongside stories from established publications and journalists. We empower individuals to share insightful viewpoints through short posts and comments. It’s essential to note our commitment to transparency: our Terms of Use acknowledge that our services may not always be error-free, and our Community Standards emphasize our discretion in enforcing policies.
-
Feb 20, 2024 |
jamanetwork.com | Brian Claggett |Outcomes Research |James C. Fang
Key PointsQuestion What is the association of initial changes in estimated glomerular filtration rate (eGFR) with cardiovascular and kidney outcomes among patients with heart failure and mildly reduced ejection fraction (HFmrEF) or preserved ejection fraction (HFpEF)?
-
Nov 9, 2023 |
medscape.com | Michelle M. Kittleson |James C. Fang
This transcript has been edited for clarity. For more episodes, download the Medscape app or subscribe to the podcast on Apple Podcasts, Spotify, or your preferred podcast provider. Michelle M. Kittleson, MD, PhD: Welcome to Medscape's InDiscussion series on heart failure. I'm your host Dr Michelle Kittleson. This is the final episode in our 12-part series, and we're capping it off by talking about the heart transplant evaluation process.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →